ArticleAdvances in therapy2020

Healthcare-Related Costs Associated with Switching Subcutaneous Tumor Necrosis Factor-α Inhibitor in the Treatment of Inflammatory Arthritis: a Retrospective Study.

Johan Dalén et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.